Bangalee, A, S Hanley, and V Bangalee. “MEDICINE AND THE LAW: Dolutegravir As First-Line Antiretroviral Therapy in South Africa: Beware the One-Size-Fits-All Approach”. South African Medical Journal 112, no. 10 (October 5, 2022): 787–790. Accessed April 18, 2026. https://samajournals.co.za/index.php/samj/article/view/256.